These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19560569)

  • 1. T-cell leukemia translocation-associated gene (TCTA) protein is required for human osteoclastogenesis.
    Kotake S; Nanke Y; Kawamoto M; Yago T; Udagawa N; Ichikawa N; Kobashigawa T; Saito S; Momohara S; Kamatani N; Yamanaka H
    Bone; 2009 Oct; 45(4):627-39. PubMed ID: 19560569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of T-cell leukemia translocation-associated gene (TCTA) protein in human osteoclastogenesis].
    Kotake S; Yago T; Kawamoto M; Nanke Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Dec; 32(6):466-71. PubMed ID: 20046013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of T-cell leukemia translocation-associated gene protein in human tumorigenesis and osteoclastogenesis.
    Kotake S; Yago T; Kawamoto M; Nanke Y
    J Biomed Biotechnol; 2012; 2012():675317. PubMed ID: 22174563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
    Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB
    Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis.
    Kim HR; Kim KW; Kim BM; Jung HG; Cho ML; Lee SH
    Arthritis Rheumatol; 2014 Mar; 66(3):538-48. PubMed ID: 24574213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
    Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P
    Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
    Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis.
    Park MK; Her YM; Cho ML; Oh HJ; Park EM; Kwok SK; Ju JH; Park KS; Min DS; Kim HY; Park SH
    Immunol Lett; 2011 Sep; 139(1-2):42-51. PubMed ID: 21620893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
    Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N
    Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes.
    Kim YG; Lee CK; Oh JS; Kim SH; Kim KA; Yoo B
    Arthritis Rheum; 2010 Feb; 62(2):515-23. PubMed ID: 20112365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
    Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
    Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
    J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim HR; Kim KW; Jung HG; Yoon KS; Oh HJ; Cho ML; Lee SH
    Arthritis Res Ther; 2011 Mar; 13(2):R43. PubMed ID: 21401926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
    Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
    Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH
    Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
    Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
    Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis.
    Kim KW; Kim HR; Kim BM; Cho ML; Lee SH
    Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.